Prevalência de dor neuropática em pacientes com osteoartrite

 

 Permissions and Reprints

Resumo

Objetivo O objetivo deste estudo foi determinar a prevalência de dor neuropática e caracterizar a qualidade de vida de pacientes com osteoartrite que consultaram um ambulatório de dor no sudoeste da Colômbia.

Métodos Este foi um estudo transversal realizado por meio de entrevista telefônica. Foram incluídos participantes ≥18 anos de idade com diagnóstico de osteoartrite. O questionário Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) foi utilizado para avaliação dos sintomas e sinais de dor neuropática e o Short Form-8 analisou a qualidade de vida.

Resultados A taxa de resposta foi de 54,1% (46/85). A razão homem:mulher foi de 5:1, com média de idade de 72 ± 10 anos. A maioria dos participantes (91,3%) apresentava dor intensa. A prevalência de dor neuropática foi de 28,3% (intervalo de confiança [IC] de 95% = 15,99-43,46) e a prevalência de dor neuropática entre mulheres foi de 84,6% (IC 95% = 54,55-98,01). Disestesias e dor paroxística foram relatadas por 92,3% dos indivíduos com dor neuropática. Em relação à qualidade de vida, as limitações na prática de atividade física foram as mais significativas e relatadas por 63% dos indivíduos.

Conclusão A dor neuropática foi prevalente e tinha impacto negativo na função física. Isso destaca a necessidade de estratégias terapêuticas direcionadas a vias específicas da dor neuropática em pacientes com osteoartrite.

Estudo desenvolvido no Departamento de Medicina Física e Reabilitação, Universidad del Valle, Cali, Colombia.

Publication History

Received: 26 December 2022

Accepted: 07 February 2023

Article published online:
08 December 2023

© 2023. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• Referências

• 1 Sen R, Hurley JA. Osteoarthritis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020
  Google Scholar
• 2 Lane NE, Shidara K, Wise BL. Osteoarthritis year in review 2016: clinical. Osteoarthritis Cartilage 2017; 25 (02) 209-215
  CrossrefPubMedGoogle Scholar
• 3 Hunter DJ, Schofield D, Callander E. The individual and socioeconomic impact of osteoarthritis. Nat Rev Rheumatol 2014; 10 (07) 437-441
  CrossrefPubMedGoogle Scholar
• 4 Kolasinski SL, Neogi T, Hochberg MC. , et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis care & research (2010). 2020; 72 (02) 149-162
  CrossrefPubMedGoogle Scholar
• 5 Hochberg MC, Altman RD, April KT. et al; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64 (04) 465-474
  CrossrefPubMedGoogle Scholar
• 6 Sakuta M. [One hundred books which built up neurology (37)-Charcot JM “Leçons sur les Localsations das les Maladies du Cerveau et de la Moelle Epinière faites a la Faculté de Médecine de Paris”(1876-1880)]. Brain Nerve 2010; 62 (01) 90-91
  PubMedGoogle Scholar
• 7 McDougall JJ, Linton P. Neurophysiology of arthritis pain. Curr Pain Headache Rep 2012; 16 (06) 485-491
  CrossrefPubMedGoogle Scholar
• 8 French HP, Smart KM, Doyle F. Prevalence of neuropathic pain in knee or hip osteoarthritis: A systematic review and meta-analysis. Semin Arthritis Rheum 2017; 47 (01) 1-8
  CrossrefPubMedGoogle Scholar
• 9 Pain IAftSo. IASP Terminology. IASP Press. https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698#Neuropathicpain . Published 1994 . Updated 14/12/17. [Accessed 05/01, 2021] .
  PubMedGoogle Scholar
• 10 Thakur M, Dickenson AH, Baron R. Osteoarthritis pain: nociceptive or neuropathic?. Nat Rev Rheumatol 2014; 10 (06) 374-380
  CrossrefPubMedGoogle Scholar
• 11 van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 2014; 155 (04) 654-662
  CrossrefPubMedGoogle Scholar
• 12 Colloca L, Ludman T, Bouhassira D. et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3: 17002
  CrossrefPubMedGoogle Scholar
• 13 Weingarten TN, Watson JC, Hooten WM. et al. Validation of the S-LANSS in the community setting. Pain 2007; 132 (1-2): 189-194
  CrossrefPubMedGoogle Scholar
• 14 López-de-Uralde-Villanueva I, Gil-Martínez A, Candelas-Fernández P, de Andrés-Ares J, Beltrán-Alacreu H, La Touche R. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Neurologia (Engl Ed) 2018; 33 (08) 505-514 (Engl Ed)
  PubMedGoogle Scholar
• 15 Vallès J, Guilera M, Briones Z, Gomar C, Canet J, Alonso J. ARISCAT Group. Validity of the Spanish 8-item short-form generic health-related quality-of-life questionnaire in surgical patients: a population-based study. Anesthesiology 2010; 112 (05) 1164-1174
  CrossrefPubMedGoogle Scholar
• 16 Clasificación estadística internacional de enfermedades y problemas relacionados con la salud: décima revisión (CIE-10), volúmenes 1, 2 y 3 en CD-Rom. Rev Esp Salud Pública 2004; 78: 647-648
  Google Scholar
• 17 Finnerup NB, Attal N, Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (02) 162-173
  CrossrefPubMedGoogle Scholar
• 18 Hochman JR, Davis AM, Elkayam J, Gagliese L, Hawker GA. Neuropathic pain symptoms on the modified painDETECT correlate with signs of central sensitization in knee osteoarthritis. Osteoarthritis Cartilage 2013; 21 (09) 1236-1242
  CrossrefPubMedGoogle Scholar
• 19 Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am 2004; 42 (01) 1-9 , v
  CrossrefPubMedGoogle Scholar
• 20 Wluka AE, Cicuttini FM, Spector TD. Menopause, oestrogens and arthritis. Maturitas 2000; 35 (03) 183-199
  CrossrefPubMedGoogle Scholar
• 21 Prieto-Alhambra D, Judge A, Javaid MK, Cooper C, Diez-Perez A, Arden NK. Incidence and risk factors for clinically diagnosed knee, hip and hand osteoarthritis: influences of age, gender and osteoarthritis affecting other joints. Ann Rheum Dis 2014; 73 (09) 1659-1664
  CrossrefPubMedGoogle Scholar
• 22 Reginato AM, Riera H, Vera M. et al; Pan-American League of Associations for Rheumatology (PANLAR) Osteoarthritis Study Group. Osteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients. J Clin Rheumatol 2015; 21 (08) 391-397
  CrossrefPubMedGoogle Scholar
• 23 Charles ST, Carstensen LL. Social and emotional aging. Annu Rev Psychol 2010; 61: 383-409
  CrossrefPubMedGoogle Scholar
• 24 Beard JR, Officer A, de Carvalho IA. et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016; 387 (10033): 2145-2154
  CrossrefPubMedGoogle Scholar
• 25 Schaible HG. Osteoarthritis pain. Recent advances and controversies. Curr Opin Support Palliat Care 2018; 12 (02) 148-153
  CrossrefPubMedGoogle Scholar
• 26 McDougall JJ, Albacete S, Schuelert N. et al. Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain. Osteoarthritis Cartilage 2017; 25 (06) 926-934
  CrossrefPubMedGoogle Scholar
• 27 Dimitroulas T, Duarte RV, Behura A, Kitas GD, Raphael JH. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum 2014; 44 (02) 145-154
  CrossrefPubMedGoogle Scholar
• 28 Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9 (05) 745-758
  CrossrefPubMedGoogle Scholar